Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 217525, 7 pages
http://dx.doi.org/10.1155/2014/217525
Research Article

A Chinese Herbal Medicine, Jia-Wei-Xiao-Yao-San, Prevents Dimethylnitrosamine-Induced Hepatic Fibrosis in Rats

1Department of Clinical Pharmacy, School of Pharmacy, Taipei Medical University, No. 250, Wuxing Street, Xinyi District, Taipei 110, Taiwan
2Department of Pharmacy, Taipei Medical University Hospital, No. 252, Wuxing Street, Xinyi District, Taipei 110, Taiwan
3Department of Pharmacy, Taipei Medical University-Wan Fang Hospital, No. 111, Section 3, Xinglong Road, Wenshan District, Taipei 116, Taiwan
4Master Program for Clinical Pharmacogenomics and Pharmacoproteomics, School of Pharmacy, Taipei Medical University, No. 250, Wuxing Street, Xinyi District, Taipei 110, Taiwan
5Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, No. 100, Shiquan 1st Road, Sanmin District, Kaohsiung 807, Taiwan
6Cancer Center, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Road, Kaohsiung 807, Taiwan
7Food and Drug Administration, Ministry of Health and Welfare, No. 161-2, Kunyang Street, Nangang District, Taipei 115, Taiwan
8Department of Healthcare Management, Yuanpei University, No. 306, Yuanpei Street, Hsinchu 300, Taiwan
9Department of Early Childhood Care and Education, Kang-Ning Junior College of Medical Care and Management, No. 137, Lane 75, Section 3, Kangning Road, Neihu District, Taipei 114, Taiwan
10Department of Nursing, School of Medicine, National Taiwan University, No. 1, Section 1, Jen Ai Road, Zhongzheng District, Taipei 100, Taiwan
11Department of Nursing, Ching-Kuo Institute of Management and Health, No. 336, Fu-Hsing Road, Zhongshan District, Keelung 203, Taiwan
12Department of Health Industry Management, School of Health Care Management, Kainan University, No. 1, Kainan Road, Luzhu Shiang, Taoyuan 338, Taiwan

Received 7 April 2014; Revised 12 May 2014; Accepted 12 May 2014; Published 3 June 2014

Academic Editor: Li-Yeh Chuang

Copyright © 2014 Shu-Chen Chien et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Ishikawa, T. Funahashi, and J. Kudo, “Effectiveness of the Kampo kami-shoyo-san (TJ-24) for tremor of antipsychotic-induced parkinsonism,” Psychiatry & Clinical Neurosciences, vol. 54, no. 5, pp. 579–582, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Yamada and S. Kanba, “Herbal medicine (Kami-shoyo-san) in the treatment of premenstrual dysphoric disorder,” Journal of Clinical Psychopharmacology, vol. 22, no. 4, p. 442, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-Y. Chen, H.-L. Chen, J.-C. Cheng et al., “A Chinese herbal medicine, Gexia-Zhuyu Tang (GZT), prevents dimethylnitrosamine-induced liver fibrosis through inhibition of hepatic stellate cells proliferation,” Journal of Ethnopharmacology, vol. 142, no. 3, pp. 811–818, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Fujimoto, “Gene therapy for liver cirrhosis,” Journal of Gastroenterology & Hepatology, vol. 15, pp. D33–D36, 2000. View at Google Scholar · View at Scopus
  5. M. Kusunose, B. Qiu, T. Cui et al., “Effect of Sho-saiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats,” Biological and Pharmaceutical Bulletin, vol. 25, no. 11, pp. 1417–1421, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Matsuda, K. Matsumoto, T. Ichida, and T. Nakamura, “Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats,” Journal of Biochemistry, vol. 118, no. 3, pp. 643–649, 1995. View at Google Scholar · View at Scopus
  7. S. C. Lin, C. C. Lin, Y. H. Lin, and C. H. Chen, “Protective and therapeutic effects of ban-zhi-lian on hepatotoxin-induced liver injuries,” American Journal of Chinese Medicine, vol. 22, no. 1, pp. 29–42, 1994. View at Google Scholar · View at Scopus
  8. A. Suzuki, M. Hagino, N. Yasuda et al., “Inhibitory effects of prostaglandin E1·α-cyclodextrin (PGE1·CD) on dimethylnitrosamine-induced acute liver damage in rats,” Folia Pharmacologica Japonica, vol. 105, no. 4, pp. 221–229, 1995. View at Google Scholar · View at Scopus
  9. A. M. Jézéquel, R. Mancini, M. L. Rinaldesi, G. Macarri, C. Venturini, and F. Orlandi, “A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat,” Journal of Hepatology, vol. 5, no. 2, pp. 174–181, 1987. View at Google Scholar · View at Scopus
  10. X. Lu, P. Liu, C. Liu et al., “Role of hepatic sinusoidal endothelium injury in hepatic fibrogenesis induced by dimethylnitrosamine in rats,” Zhonghua Gan Zang Bing Za Zhi, vol. 10, no. 6, pp. 441–444, 2002. View at Google Scholar · View at Scopus
  11. D. Wu and A. I. Cederbaum, “Ethanol cytotoxicity to a transfected HepG2 cell line expressing human cytochrome P4502E1,” Journal of Biological Chemistry, vol. 271, no. 39, pp. 23914–23919, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Yuda, J. Tanaka, F. Hirano, K. Igarashi, and T. Satoh, “Participation of lipid peroxidation in rat pertussis vaccine pleurisy. III. Thiobarbituric acid (TBA) reactant and lysosomal enzyme,” Chemical and Pharmaceutical Bulletin, vol. 39, no. 2, pp. 505–506, 1991. View at Google Scholar · View at Scopus
  13. J. M. McCord and I. Fridovich, “The reduction of cytochrome c by milk xanthine oxidase,” Journal of Biological Chemistry, vol. 243, no. 21, pp. 5753–5760, 1968. View at Google Scholar · View at Scopus
  14. W. M. Frederiks and K. S. Bosch, “The role of xanthine oxidase in ischemia/reperfusion damage of rat liver,” Histology & Histopathology, vol. 10, no. 1, pp. 111–116, 1995. View at Google Scholar · View at Scopus
  15. E. C. Viel, K. Benkirane, D. Javeshghani, R. M. Touyz, and E. L. Schiffrin, “Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats,” American Journal of Physiology: Heart and Circulatory Physiology, vol. 295, no. 1, pp. H281–H288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Poynard, P. Bedossa, and P. Opolon, “Natural history of liver fibrosis progression in patients with chronic hepatitis C,” The Lancet, vol. 349, no. 9055, pp. 825–832, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Wang, M.-Y. Xu, R.-D. Zheng et al., “Prediction of significant fibrosis and cirrhosis in hepatitis B e-antigen negative patients with chronic hepatitis B using routine parameters,” Hepatology Research, vol. 43, no. 5, pp. 441–451, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. G. S. Baroni, L. D'Ambrosio, P. Curto et al., “Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis,” Hepatology, vol. 23, no. 5, pp. 1189–1199, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Giannelli, C. Bergamini, F. Marinosci et al., “Antifibrogenic effect of IFN-α2b on hepatic stellate cell activation by human hepatocytes,” Journal of Interferon & Cytokine Research, vol. 26, no. 5, pp. 301–308, 2006. View at Google Scholar · View at Scopus
  20. D. Schuppan, A. Krebs, M. Bauer, and E. G. Hahn, “Hepatitis C and liver fibrosis,” Cell Death & Differentiation, vol. 10, no. 1, pp. S59–S67, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Yoshiji, R. Noguchi, S. Kuriyama et al., “Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats,” American Journal of Physiology: Gastrointestinal & Liver Physiology, vol. 288, no. 5, pp. G907–G913, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Shimizu, Y.-R. Ma, Y. Mizobuchi et al., “Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats,” Hepatology, vol. 29, no. 1, pp. 149–160, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Bedossa, K. Houglum, C. Trautwein, A. Holstege, and M. Chojkier, “Stimulation of collagen α1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue fibrosis?” Hepatology, vol. 19, no. 5, pp. 1262–1271, 1994. View at Google Scholar · View at Scopus
  24. G. Vendemiale, I. Grattagliano, M. L. Caruso et al., “Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: effect of N-acetylcysteine and interferon-α,” Toxicology and Applied Pharmacology, vol. 175, no. 2, pp. 130–139, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Lu, I. Shimizu, X. Cui et al., “Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats,” Life Sciences, vol. 74, no. 7, pp. 897–907, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. K. S. Lee, M. Buck, K. Houglum, and M. Chojkier, “Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression,” The Journal of Clinical Investigation, vol. 96, no. 5, pp. 2461–2468, 1995. View at Google Scholar · View at Scopus
  27. R. H. Shi, T. X. Chen, and X. Z. Lu, “Protective effects of free radical scavengers superoxide dismutase and catalase on experimental liver fibrosis,” Zhonghua Xiaohua Zazhi, vol. 13, pp. 84–86, 1993. View at Google Scholar